The Wall Street Journal’s Lauren Weber on the ways employers are trying to get workers to lose weight in an effort to reduce costs.
Golden Corral Franchises SVP Bob McDevitt on why the chain stays open on Thanksgiving.
Advantage Payroll Services President Rob Basso, Independent Women’s Forum’s Hadley Heath Manning and FBN’s Tracy Byrnes on the impact of the protests in Ferguson on America’s image and the FDA crackdown on calories.
Apple Metro Chairman Zane Tankel weighs in on the new calorie count and menu labeling ObamaCare regulations coming.
FBN’s Lori Rothman on the cost of the FDA ’s new rules that require calorie counts to be printed on menus at restaurants.
CKO Kickboxing Owner Jacqueline Gomes and FBN’s Charlie Gasparino on the FDA ’s new rules that require calorie counts to be printed on menus at restaurants.
Retailers report strong October sales
Edwards Lifesciences CEO Mike Mussallem on creating new technology to combat heart disease.
Hampton Creek Founder Josh Tetrick discusses Unilever’s lawsuit against the company.
David Benoit and Liz Hoffman of The Wall Street Journal on activist investor Bill Ackman’s new stake in animal health company Zoetis.
How the D.C. overlords stay in power
’The Independents’ co-host Matt Welch and Dan Clifton of Strategas Research Partners discuss the impact of a Trans-Pacific Partnership and President Obama’s remarks on net neutrality.
Monster Worldwide Senior V.P. Joanie Courtney, A&G Capital CIO Hilary Kramer, Republican Strategist Dee Dee Benkie, Penn Financial Group founder Matt McCall and FBN’s Charles Payne and Tom Sullivan on the state of the U.S. economy and the obstacles to achieving the American dream.
Mashable Senior Technology Editor Pete Pachal discusses the FAA drone battle, and how Sony trashed Angelina Jolie.
Strategas Head of Policy Research Dan Clifton and Haverford Trust CIO Hank Smith discuss MIT economics professor Jonathan Gruber’s hearing before the House Oversight Committee, the impact of Obamacare on businesses, and government spending.
NYU School of Medicine’s Dr. Devi Nampiaparampil discusses the effectiveness of Merck’s new cancer drug.
Merck CEO Kenneth Frazier discusses the motivation behind the $8.4 billion deal to buy Cubist, and the drugmaker’s strategy to constantly look for value-creating opportunities.
Next Glass Co-Founder Trace Smith on how the app helps users choose their next glass of wine.
CKE Restaurants CEO Andrew Puzder on the new menu labeling policy for restaurants announced by the FDA .
Suneris CEO Joe Landolina on inventing gel that helps stop bleeding.